logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8598202 B1

PDFFull Text
Expired
Date of Patent:
Dec. 03, 2013

Filed:

Feb. 18, 2009

Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase

Applicants:

Richard Apodaca, La Jolla, CA (US);

J. Guy Breitenbucher, Escondido, CA (US);

Alison L. Chambers, San Diego, CA (US);

Xiaohu Deng, San Diego, CA (US);

Natalie A. Hawryluk, San Diego, CA (US);

John M. Keith, San Diego, CA (US);

Neelakandha S. Mani, San Diego, CA (US);

Jeffrey E. Merit, Stanford, CA (US);

Joan M. Pierce, San Diego, CA (US);

Mark Seierstad, Escondido, CA (US);

Wei Xiao, San Diego, CA (US);

Inventors:

Richard Apodaca, La Jolla, CA (US);

J. Guy Breitenbucher, Escondido, CA (US);

Alison L. Chambers, San Diego, CA (US);

Xiaohu Deng, San Diego, CA (US);

Natalie A. Hawryluk, San Diego, CA (US);

John M. Keith, San Diego, CA (US);

Neelakandha S. Mani, San Diego, CA (US);

Jeffrey E. Merit, Stanford, CA (US);

Joan M. Pierce, San Diego, CA (US);

Mark Seierstad, Escondido, CA (US);

Wei Xiao, San Diego, CA (US);

Assignee:

Janssen Pharmaceutica NV, Beerse, BE;

Attorney:

Michael J. Atkins

Primary Examiner:

Paul V Ward

Int. Cl.
CPC ...
A01N 43/54 (2006.01); A61K 31/505 (2006.01);
U.S. Cl.
CPC ...
Abstract

Certain aryl-hydroxyethylamino-pyrimidine and triazine compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). Methods of synthesizing such compounds are also disclosed.

Find Patent Forward Citations

Apodaca, Richard. (2013). Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase (U.S. Patent No. 8598202). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8598202

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…